Estrogen receptor 1 (ESR1) genetic variations in cancer risk: a systematic review and meta-analysis

Clin Res Hepatol Gastroenterol. 2015 Feb;39(1):127-35. doi: 10.1016/j.clinre.2014.07.016. Epub 2014 Sep 15.

Abstract

Background: Emerging published data on the association between single nucleotide polymorphisms (SNPs) in the estrogen receptor 1 (ESR1) gene and cancer susceptibility are inconsistent. This review and meta-analysis is performed to derive a more precise evaluation of this relationship.

Methods: The literature search of PubMed, Embase, Web of Science and CNKI databases was conducted from their inception through June 2014. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to assess the association.

Results: Twenty-two literatures were enrolled in this meta-analysis. The results indicated that ESR1 rs1801132 (C>G) was associated with cancer risk in Caucasian populations. However, the results of stratified analysis by cancer type and source of controls indicated that no significant association was found. Furthermore, rs2077647 (A>G) was only associated with an increased risk of hepatocellular carcinoma, but was an adverse effect on cancer risk in Caucasian populations.

Conclusions: This present meta-analysis indicated that rs1801132 (C>G) and rs2077647 (A>G) may be protective factors in Caucasian populations. Meanwhile, rs2077647 (A>G) may be closely related with hepatocellular carcinoma.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Carcinoma, Hepatocellular / epidemiology
  • Carcinoma, Hepatocellular / genetics*
  • Estrogen Receptor alpha / genetics*
  • Genetic Variation
  • Humans
  • Liver Neoplasms / epidemiology
  • Liver Neoplasms / genetics*
  • Risk

Substances

  • ESR1 protein, human
  • Estrogen Receptor alpha